Marya D Zilberberg

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Topics

Urinary Tract Infection

Cross Sectional

Community Acquired Pneumonia

Top Venues

ClinicoEconomics and outcomes research : CEOR

Open forum infectious diseases

Infection control and hospital epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Marya D Zilberberg, Brian H Nathanson, Katherine Sulham, John F Mohr, Matthew M Goodwin, Andrew F Shorr
Descriptive Epidemiology and Outcomes of Patients with Short Stay Hospitalizations for the Treatment of Congestive Heart Failure in the US. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Marya D Zilberberg, Brian H Nathanson, Kate Sulham, John F Mohr, Matthew Goodwin, Andrew F Shorr
Examining the Burden of Potentially Avoidable Heart Failure Hospitalizations. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Marya D Zilberberg, Brian H Nathanson, Katherine Sulham, John F Mohr, Matthew M Goodwin, Andrew F Shorr
Descriptive Epidemiology and Outcomes of Patients with Short Stay Hospitalizations for the Treatment of Congestive Heart Failure in the US. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Marya D Zilberberg, Brian H Nathanson, Laura A Puzniak, Noah W D Zilberberg, Andrew F Shorr
Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014-2019. PloS one 17 (12) (2022)
Marya D Zilberberg, Brian H Nathanson, Laura A Puzniak, Noah W D Zilberberg, Andrew F Shorr
Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014-2019. PloS one 17 (12) (2022)
Marya D Zilberberg, Brian H Nathanson, Laura A Puzniak, Noah W D Zilberberg, Andrew F Shorr
Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014-2019. PloS one 17 (12) (2022)
Marya D Zilberberg, Brian H Nathanson, Laura A Puzniak, Noah W D Zilberberg, Andrew F Shorr
Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014-2019. PloS one 17 (12) (2022)
Michael B Rothberg, Sarah Haessler, Abhishek Deshpande, Pei-Chun Yu, Peter K Lindenauer, Marya D Zilberberg, Thomas L Higgins, Peter B Imrey
Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia. Infection control and hospital epidemiology (2022)
Marya D Zilberberg, Brian H Nathanson, Laura A Puzniak, Noah W D Zilberberg, Andrew F Shorr
Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014-2019. PloS one 17 (12) (2022)
Marya D Zilberberg, Brian H Nathanson, Kate Sulham, Andrew F Shorr
Descriptive epidemiology and outcomes of emergency department visits with complicated urinary tract infections in the United States, 2016-2018. Journal of the American College of Emergency Physicians open 3 (2) (2022)
Marya D Zilberberg, Brian H Nathanson, Laura A Puzniak, Andrew F Shorr
Microbiology, empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014-2019. Infection control and hospital epidemiology 43 (3) (2022)
Marya D Zilberberg, Brian H Nathanson, Kate Sulham, Andrew F Shorr
Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018. Open forum infectious diseases 9 (1) (2022)
Marya D Zilberberg, Brian H Nathanson, Kate Sulham, Andrew F Shorr
Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013-2018: a retrospective cohort study. BMC infectious diseases 21 (1) (2021)
Marya D Zilberberg, Brian H Nathanson, Kristen Ditch, Kenneth Lawrence, Melanie Olesky, Andrew F Shorr
Carbapenem Treatment and Outcomes Among Patients With Culture-Positive Complicated Intra-abdominal Infections in US Hospitals: A Retrospective Cohort Study. Open forum infectious diseases 6 (12) (2019)